PRUDENTIAL FINANCIAL INC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 93 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRUDENTIAL FINANCIAL INC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,038,052
-25.4%
303,560
+71.4%
0.02%
-17.4%
Q2 2023$16,131,988
+37.9%
177,080
-0.1%
0.02%
+27.8%
Q1 2023$11,697,281
+27.5%
177,339
-0.0%
0.02%
+20.0%
Q4 2022$9,172,371
-25.8%
177,381
-2.2%
0.02%
-28.6%
Q3 2022$12,367,000
+63.1%
181,374
+8.2%
0.02%
+75.0%
Q2 2022$7,581,000
-55.1%
167,630
-49.5%
0.01%
-45.5%
Q1 2022$16,879,000
+93.1%
332,202
+84.3%
0.02%
+100.0%
Q4 2021$8,741,000
+54.7%
180,270
+5.2%
0.01%
+37.5%
Q3 2021$5,650,000
-51.5%
171,395
-6.9%
0.01%
-50.0%
Q2 2021$11,638,000
+64.4%
184,140
+11.6%
0.02%
+45.5%
Q1 2021$7,078,000
-24.9%
164,960
+0.1%
0.01%
-31.2%
Q4 2020$9,425,000
+151.4%
164,760
+32.6%
0.02%
+128.6%
Q3 2020$3,749,000
+28.6%
124,270
+39.2%
0.01%
+16.7%
Q2 2020$2,915,000
+23.0%
89,254
+0.9%
0.01%
+20.0%
Q1 2020$2,370,000
+6.8%
88,462
+22.0%
0.01%
+66.7%
Q4 2019$2,219,000
-15.7%
72,496
-32.8%
0.00%
-25.0%
Q3 2019$2,633,000
-23.1%
107,860
-20.2%
0.00%
-20.0%
Q2 2019$3,423,000
+10.5%
135,080
-15.0%
0.01%0.0%
Q1 2019$3,099,000
+4.8%
158,940
-28.8%
0.01%0.0%
Q4 2018$2,958,000
-9.7%
223,260
+21.3%
0.01%0.0%
Q3 2018$3,274,000
+10.3%
184,130
+36.5%
0.01%
+25.0%
Q2 2018$2,968,000134,9000.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders